Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (15 ops.)
Latest filing published 17 Jul 2025 for LIFECORE BIOMEDICAL, INC. \DE\.
Filing timeline
BuySaleMatthew E. Korenberg
Insider track record
Disclosed buys
1
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Matthew E. Korenberg: trading record in brief
Matthew E. Korenberg, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Ligand Pharmaceuticals Inc and Lifecore Biomedical, Inc. \DE\. The record holds 95 filings, for trades running from 6 August 2015 to 15 July 2025.
In open-market terms, that means 1 purchase worth €39k on one side and 15 sales worth €11.1M on the other. Netting one side against the other leaves €11.1M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 61 share grants and 8 option exercises.
The record was last updated on 17 July 2025 with a share grant in Lifecore Biomedical, Inc. \DE\. The last insider purchase was made public on 3 September 2019, 2,607 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Matthew E. Korenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
19,506 sharesCommon StockSEC:0001005286-25-000090:0
4,982 shares@ US$49.995.9% of flowCommon StockSEC:0002001011-24-000087:0
914 shares@ US$55.751.2% of flowCommon StockSEC:0002001011-24-000082:0
1,157 shares@ US$105.542.9% of flowCommon StockSEC:0002001011-24-000078:0
24,554 sharesCommon StockSEC:0001628280-24-038088:0
18,245 shares@ US$98.5043.3% of flowCommon StockSEC:0002001011-24-000071:0
350 shares@ US$60.7070.5% of flowCommon StockSEC:0002001011-24-000064:0
3,440 shares@ US$84.54317.1% of flowCommon StockSEC:0002001011-24-000052:0
14,416 shares0Common StockSEC:0002001011-24-000029:0
4,778 shares@ US$74.658.7% of flowCommon StockSEC:0002001011-24-000018:0
2,917 shares@ US$72.315.0% of flowCommon StockSEC:0002001011-24-000009:0
1,984 shares@ US$59.612.9% of flowCommon StockSEC:0002001011-23-000003:0
376 shares@ US$56.780.5% of flowCommon StockSEC:0000886163-23-000045:0
9,069 shares0Common StockSEC:0000899243-23-006297:0
2,890 shares@ US$72.985.2% of flowCommon StockSEC:0000899243-23-005552:0
3,859 shares@ US$66.296.3% of flowCommon StockSEC:0000899243-22-039583:0
14,000 shares0Common StockSEC:0000899243-22-038699:0
3,593 shares@ US$72.906.7% of flowCommon StockSEC:0000899243-22-037330:0
27,714 shares0Common StockSEC:0000899243-22-035047:0
164 shares@ US$75.8370.3% of flowCommon StockSEC:0000886163-22-000107:0
8,062 shares0Common StockSEC:0000886163-22-000090:0
906 shares@ US$123.682.6% of flowCommon StockSEC:0000886163-22-000021:0
4,803 shares0Common StockSEC:0000886163-22-000014:0
247 shares@ US$85.90950.5% of flowCommon StockSEC:0000886163-21-000097:0
3,870 sharesCommon StockSEC:0000886163-16-000144:0
25 of 25 declarations
